サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：血管移植片の世界市場-2023-2030
市場調査レポート
商品コード
1279682

血管移植片の世界市場-2023-2030

Global Vascular Graft Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
血管移植片の世界市場-2023-2030
出版日: 2023年05月26日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場の概要

血管移植片の世界市場は、2022年に24億8,330万米ドルに達し、2030年には最大で44億400万米ドルに達するなど、有利な成長が予測されます。血管移植片市場は、予測期間中（2023年～2030年）に7.6%のCAGRを示すと予測されています。

血管移植片は、血管バイパス治療の際に血管をつなぎ、血流をある場所から別の場所に誘導する医療機器です。様々な外科手術の際に、血管の狭窄を回避し、傷ついた部分の血流を回復させ、心臓発作や脳卒中などの問題を回避するのに役立ちます。

心血管疾患の頻度の増加、血管手術の技術的改善、人口の高齢化などが、予測期間中の世界の血管移植片市場の成長に寄与すると予想されます。

市場力学

透析処置数の増加と慢性腎臓病（CKD）症例の増加が、世界の血管移植片市場の成長を牽引すると予想されます。

世界の透析処置数の増加と慢性腎臓病（CKD）の症例数の増加が、世界の血管移植片市場の成長を牽引しています。CKDは変性疾患であり、現在、世界中で8億人以上の人が罹患しています。例えば、2022年にJournal Kidney International Supplementsに掲載された調査によると、CKDの有病率の上昇により、透析処置における血管移植片の需要が増加するとされています。

さらに、米国腎臓基金の報告によると、腎臓病は約3,700万人のアメリカ人に影響を与え、同国の死亡原因のトップ10の1つである腎不全は、約81万人に影響を与えるとされています。したがって、上記の要因によって、血管移植片の世界市場は予測期間中に成長を示すことになります。

血管移植片の世界市場は、血管移植片の高コスト別制約に直面する可能性があります

血管移植片に関連する高コストは、世界の血管移植片市場の成長に対する主な抑制要因です。血管移植片の価格は、使用する材料の種類や手術の複雑さによって異なり、例えば、合成血管移植片は生物学的なものよりも安価になる傾向がありますが、必ずしも成功するとは限りません。そのため、低開発国の患者や保険に加入していない患者にとっては、高価な製品であるため、購入できない可能性があります。

COVID-19影響分析

事業運営、サプライチェーン、流通システムなどの混乱により、COVID-19の発生は血管移植片の市場にマイナスの影響を与えました。コロナウイルスの拡散を食い止めるため、他の選択的手術がキャンセルされたり、延期されたりしました。さらに、ヘルスケア担当者がCOVID-19の治療に専念していたため、不要不急の手術が少なくなっていました。

ロシア・ウクライナ紛争分析

血管移植片の世界市場は、ロシアとウクライナの紛争によって特に影響を受けていません。紛争は地政学的な不安と経済制裁を引き起こしたが、血管移植片の生産と流通はロシアとウクライナのいずれにも大きく依存していないです。血管移植片の市場参入企業の大半は、世界中に事業所と供給網を持つ多国籍企業です。

血管移植片は医療用として使用されることが多く、地政学的な影響を受けるというよりは、患者の要望やヘルスケアに関する規制によって需要が大きく左右されます。ロシア・ウクライナ戦争は、血管移植片の入手に一時的かつ小規模な影響を及ぼすと予想されますが、この地域の紛争や不安定な状況が長引けば、血管移植片市場を含む世界のヘルスケア産業に広く影響を与える可能性があります。

目次

第1章 調査手法とスコープ

  • 調査手法
  • 調査目的および調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

  • 製品別
  • 原材料別
  • エンドユーザー別
  • 地域別

第4章 市場力学

  • 影響要因
    • 促進要因
      • 透析患者数の増加、慢性腎臓病（CKD）の患者数の増加
    • 抑制要因
      • 血管移植片の高いコスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 法規制の分析

第6章 COVID-19の分析

  • COVID-19の分析
    • COVID-19登場前シナリオ
    • 現在のCOVID-19シナリオ
    • COVID-19後のシナリオ、または将来のシナリオ
  • COVID-19の中での価格・ダイナミクス
  • 需給スペクトル
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • サマリー

第7章 製品別

  • 血液透析アクセスグラフト
  • 血管内動脈瘤修復ステントグラフト
  • 末梢血管用グラフト

第8章 原材料別

  • ポリエステル
  • ポリテトラフルオロエチレン（PTFE）
  • ポリウレタン
  • 生合成

第9章 エンドユーザー別

  • 病院
  • 専門クリニック
  • 外来手術センター

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A（合併・買収）分析

第12章 企業プロファイル

  • Abbott Laboratories
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展状況
  • Braun Melsungen AG
  • Bard Peripheral Vascular Inc.（BD）
  • Cardinal Health（Cordis Corporation）
  • Cook Medical
  • Cryolife
  • Getinge Group
  • LeMaitre Vascular Inc
  • Medtronic PLC
  • W.L. Gore & Associates Inc

第13章 付録

目次
Product Code: MD747

Market Overview

The global vascular graft market reached US$ 2,483.3 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 4,404.0 million by 2030. The vascular graft market is expected to exhibit a CAGR of 7.6% during the forecast period (2023-2030).

Vascular grafts are medical devices that connect blood vessels during vascular bypass treatments to redirect blood flow from one location to another. They help to circumvent constrictions in blood arteries, restore blood flow to injured areas, and avoid problems like heart attacks and strokes during a variety of surgical operations.

The rising frequency of cardiovascular illnesses, technical improvements in vascular surgery, and the aging population are all expected to contribute to the global vascular graft market growth over the forecast period.

Market Dynamics

The Rising Number of Dialysis Procedures and a Rise in Cases of Chronic Kidney Disease (CKD) Are Expected to Drive the Global Vascular Graft Market Growth.

The growing number of dialysis procedures and a rise in cases of chronic kidney disease (CKD) worldwide are driving the growth of the global vascular graft market. CKD is a degenerative disease that now affects more than 800 million people worldwide. For instance, according to research that was published in the Journal Kidney International Supplements in 2022, the rising prevalence of CKD will increase the demand for vascular grafts in dialysis procedures.

Furthermore, according to the report by the American Kidney Fund, renal disease affects approximately 37 million Americans, and kidney failure, one of the top 10 leading causes of mortality in the country, affects around 810,000 people. Therefore, owing to the above factors, the global vascular graft market will witness growth over the forecast period.

The Global Vascular Graft Market May Face Constraints Due to High Cost of Vascular Grafts.

The high cost associated with the vascular graft is the major restraint for global vascular graft market growth. The vascular graft prices vary based on the kind of material used and how complicated the surgery is, for instance, synthetic grafts tend to be less expensive than biological ones, but they might not always be as successful. The products could not be affordable for patients in underdeveloped nations or for those without insurance because of their high price.

COVID-19 Impact Analysis

Due to the disruption in business operations, supply chains, distribution systems, etc., the COVID-19 outbreak had a negative effect on the market for vascular grafts. In order to stop the coronavirus from spreading, other elective procedures were either cancelled or put off. Additionally, because healthcare providers were concentrating on COVID-19 treatment, fewer non-essential surgeries were performed.

Russia Ukraine Conflict Analysis

The world market for vascular grafts has not been specifically impacted by the conflict between Russia and Ukraine. Although the conflict has caused geopolitical unrest and economic sanctions, the production and distribution of vascular grafts are not heavily reliant on either Russia or Ukraine. The majority of the top market participants for vascular grafts are multinational corporations with operations and supply networks dispersed around the globe.

Vascular grafts are mostly employed in medical treatments, and rather than being influenced by geopolitics, the demand for these devices is largely driven by patient demands and healthcare regulations. The Russia-Ukraine war is only anticipated to have a transient and small-scale impact on the availability of vascular grafts, , but any prolonged conflict or instability in the region could have wider implications for the global healthcare industry, including the vascular grafts market.

Segment Analysis

The global vascular graft market is segmented based on product, raw material, end user, and region.

The Hospitals Segment is Expected to Dominate the Global Vascular Graft Market.

The hospitals sgement dominated the global vascular graft market and accounted the highest vascular graft market share of 38.3%. Vascular grafting is one of the many surgical procedures that have become more common in hospitals as a result of the rising burden of chronic illnesses including cardiovascular disease and chronic renal disease. As a result, hospitals make up the majority of vascular transplant end users.

The expansion of the hospital end user sector is also being fueled by the availability of public and private insurance programmes for hospital treatments. Vascular graft surgeries can be obtained by patients through insurance plans, which increases their accessibility and affordability. Therefore, owing to the above factors, the hospiatals segment is likely to play major role in accelarating the global vascular graft market growth.

Geographical Analysis

North America Region Holds The Largest Market Share of the Global Vascular Graft Market.

The global vascular graft market is dominated by North America and holds 1/3rd market share, due to the high prevalence of diabetes, cardiovascular disease, and chronic kidney disease. The expansion of this market in North America is being fueled by the presence of reimbursement coverage and the accessibility of cutting-edge healthcare infrastructure. The expansion of biomaterials vascular grafts is sparked by ongoing technical advancements that are followed by the identification of particular goods made via tissue engineering.

Furthermore, the better reimbursement policies, cutting-edge technology, effective initiatives, and precise diagnostic processes using biometric instruments are some of the major contributors to the market's growth. Moreover, it is anticipated that ongoing research into the creation of advanced biomaterial grafts will increase demand for these products in the area.

Competitive Landscape

The major global players in the market include: Abbott Laboratories, Braun Melsungen AG, Bard Peripheral Vascular Inc., Cardinal Health (Cordis Corporation), Cook Medical, Cryolife, Getinge Group, LeMaitre Vascular Inc, Medtronic PLC, and W.L. Gore & Associates Inc.

Why Purchase the Report?

  • To visualize the global vascular graft market segmentation based on product, raw material, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global vascular graft market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global vascular graft market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Raw Material
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising number of dialysis procedures and a rise in cases of chronic kidney disease (CKD)
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of vascular grafts.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Hemodialysis Access Graft
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Endovascular Aneurysm Repair Stent Graft
  • 7.4. Peripheral Vascular Graft

8. By Raw Material

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 8.1.2. Market Attractiveness Index, By Raw Material
  • 8.2. Polyester
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Polytetrafluoroethylene (PTFE)
  • 8.4. Polyurethane
  • 8.5. Biosynthetic

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Ambulatory Surgery Center

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Abbott Laboratories*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Braun Melsungen AG
  • 12.3. Bard Peripheral Vascular Inc. (BD)
  • 12.4. Cardinal Health (Cordis Corporation)
  • 12.5. Cook Medical
  • 12.6. Cryolife
  • 12.7. Getinge Group
  • 12.8. LeMaitre Vascular Inc
  • 12.9. Medtronic PLC
  • 12.10. W.L. Gore & Associates Inc

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us